Proteome Sciences
PRM · AIM · Health Care · mcap £5.3m · 1.4p
Financials · LTM to 30 Jun 26
Source: results 16 Sep 26 ↗
- Revenue
- £3.8m
- Operating profit
- −£2.3m
- Net income
- −£2.3m
- Free cash flow
- −£250k
- Net debt
- £13.8m
- Market cap
- £4.8m
- EV / EBIT
- –
- FCF yield
- −5.3%
- Price / book
- –
Latest half-year · H1 26 vs H1 25
results 16 Sep 26 ↗
- Revenue
- £1.9m +1%
- Operating profit
- −£1.2m prior −£1.6m
- Net income
- −£1.4m prior −£2.1m
- Cash from operations
- −£428k prior −£897k
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Latest report: H1 26 (six months to 30 Jun 26), published 16 Sep 26 · read the results ↗
£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source
| LTM Jun 26 | FY 25 | FY 24 | |
|---|---|---|---|
| Revenue | 3.8 | 3.8 | 4.9 |
| Gross profit | 0.0 | (0.1) | 0.7 |
| Adjusted EBITDA | – | (1.7) | (1.5) |
| EBITDA | – | (1.7) | (1.5) |
| Operating profit | (2.3) | (2.7) | (2.4) |
| Depreciation (owned assets) | – | 0.2 | 0.1 |
| Depreciation (right-of-use) | – | 0.7 | 0.7 |
| Share-based payments | 0.0 | 0.0 | 0.0 |
| Finance costs | (0.9) | (0.9) | (0.9) |
| Profit before tax | (3.2) | (3.6) | (3.2) |
| Tax | 0.9 | 0.5 | (0.2) |
| Net income (owners) | (2.3) | (3.1) | (3.4) |
| EPS basic | (0.7p) | (1.0p) | (1.1p) |
| EPS diluted | (0.7p) | (1.0p) | (1.1p) |
| H1 26 | vs H1 25 | H2 25 | H1 25 | |
|---|---|---|---|---|
| Revenue | 1.9 | +1% | 1.9 | 1.9 |
| Gross profit | 0.4 | +35% | (0.4) | 0.3 |
| Operating profit | (1.2) | n/m | (1.0) | (1.6) |
| Share-based payments | 0.0 | n/m | (0.0) | 0.0 |
| Finance costs | (0.5) | +3% | (0.5) | (0.5) |
| Profit before tax | (1.7) | n/m | (1.5) | (2.1) |
| Tax | 0.3 | n/m | 0.6 | (0.1) |
| Net income (owners) | (1.4) | n/m | (0.9) | (2.1) |
| EPS basic | (0.4p) | – | (0.3p) | (0.7p) |
| EPS diluted | (0.4p) | – | (0.3p) | (0.7p) |
| Latest Jun 26 | FY 25 | FY 24 | |
|---|---|---|---|
| Goodwill | 4.2 | 4.2 | 4.2 |
| Property, plant & equipment | 0.5 | 0.5 | 0.6 |
| Inventories | 0.4 | 0.5 | 0.7 |
| Trade receivables | 0.2 | 0.6 | 0.4 |
| Cash | 1.1 | 0.8 | 1.1 |
| Total assets | 7.7 | 8.3 | 9.1 |
| Trade payables | 1.2 | 1.6 | 0.8 |
| Borrowings, current | 14.9 | 14.5 | 12.6 |
| Lease liabilities, current | 0.5 | 0.5 | 0.6 |
| Borrowings, non-current | – | 0.0 | 0.2 |
| Lease liabilities, non-current | 0.5 | 0.8 | 1.0 |
| Pension surplus / (deficit) | (0.4) | (0.4) | – |
| Total liabilities | 17.6 | 17.8 | 15.7 |
| Total equity | (9.9) | (9.5) | (6.6) |
| H1 26 | H2 25 | H2 24 | |
|---|---|---|---|
| Goodwill | 4.2 | 4.2 | 4.2 |
| Property, plant & equipment | 0.5 | 0.5 | 0.6 |
| Inventories | 0.4 | 0.5 | 0.7 |
| Trade receivables | 0.2 | 0.6 | 0.4 |
| Cash | 1.1 | 0.8 | 1.1 |
| Total assets | 7.7 | 8.3 | 9.1 |
| Trade payables | 1.2 | 1.6 | 0.8 |
| Borrowings, current | 14.9 | 14.5 | 12.6 |
| Lease liabilities, current | 0.5 | 0.5 | 0.6 |
| Borrowings, non-current | – | 0.0 | 0.2 |
| Lease liabilities, non-current | 0.5 | 0.8 | 1.0 |
| Pension surplus / (deficit) | (0.4) | (0.4) | – |
| Total liabilities | 17.6 | 17.8 | 15.7 |
| Total equity | (9.9) | (9.5) | (6.6) |
Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.
Company filings. Not investment advice.